series-c-plus
Stage
1
Investors
About
Lumicell develops a fluorescence-guided intraoperative imaging system and companion imaging agent (pegulicianine) to help surgeons detect residual cancer in real time during breast cancer surgery. Their FDA-approved LumiSystem includes the LUMISIGHT imaging agent and the Lumicell DVS device.
Explore Lumicell's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.